Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study

BMC Pulmonary Medicine

Table 2 Inhaled Corticosteroid (ICS) use and risk of Herpes Zoster in 8900 cases and 88032 controls

	Cases	Controls	Crude odds ratio	Adjusted odds ratio* (95% CI†)
ICS
no use%	45.4	46.9	1.00	Reference
high dose%	13.1	11.6	1.19	1.05 (0.96-1.14)
medium dose%	14.3	14.7	1.01	0.97 (0.90-1.05)
low dose%	2.9	2.9	1.05	1.02 (0.89-1.17)

*Adjusted for gender, smoking status, all the variables in Table 1, as well as past use of ICS.
†CI: confidence interval

ISSN: 1471-2466